Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Chloroform | HCID 6212 | — |
| Reactant | Potassium hydroxy sulfite | HCID 23707502 | — |
| Reactant | HCID 88040330 | HCID 88040330 | — |
| Product | HCID 88040420 | HCID 88040420 | 68% |
Reaction Steps
Oxone® (370 mg, 0.6 mmol) was added to a suspension of (1R*,2R*,5S*,6R*)-8-benzyl-2-{[3,5-bis(trifluoromethyl)phenyl]methoxy}-6-(2-methylthiomethyl-2H-tetrazol-5-yl)-1-phenyl-8-azabicyclo[3.2.1]octane (Compound 3 g in Table 3; 130 mg, 0.2 mmol) and wet alumina (200 mg) in chloroform (10 ml). The mixture was heated to 50° C. for 18 hours, then filtered through Celite™ and the filtrate concentrated in vacuo to yield the title compound (92 mg, 68%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06727249B2 |
|---|
| Source dataset | uspto-grants-2004_04 |
|---|
| ORD ID | ord-96fb7aea061b4284900385b4ea2276ee |
|---|
| Source note | uspto-grants-2004_04 |
|---|